Surface Oncology (SURF) IPO Opens Modestly Lower

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/19/2026

1. VRNS
2. JBHT
3. CRWV
4. TSLA
5. SCHW
6. GPRK
7. TFC
8. TRV
9. FFAI
10. USB

Go back to Surface Oncology (SURF) IPO Opens Modestly Lower

Surface Oncology Announces $119.5 Million Aggregate Financing, Consisting of $108.0 Million Initial Public Offering and $11.5 Million Concurrent Private Placement

April 18, 2018 9:00 PM EDT

CAMBRIDGE, Mass., April 18, 2018 (GLOBE NEWSWIRE) -- Surface Oncology, Inc. (Surface) (Nasdaq: SURF), a clinical-stage immuno-oncology company developing next-generation antibody therapies that target the tumor microenvironment, today announced the pricing of its initial public offering of 7,200,000 shares of common stock at a public offering price of $15.00 per share. In addition, Surface has granted the underwriters a 30-day option to purchase up to 1,080,000 additional shares of common stock at the initial public offering price, less the underwriting discount. The gross proceeds from the offering, before deducting underwriting discounts and estimated offering expenses, are expected to be... More